Vaxart to Present at World Vaccine Congress Europe 2023 on October 18-19
October 11 2023 - 8:00AM
Vaxart, Inc. (Nasdaq: VXRT) today announced that Dr. Sean Tucker,
Founder and Chief Scientific Officer, and Dr. James F. Cummings,
Chief Medical Officer, will present at the World Vaccine Congress
Europe 2023 in Barcelona, Spain on Wednesday, October 18 and
Thursday, October 19, 2023.
Presentation Information:
Title: Transmission blocking
strategies via oral tablet vaccination and mucosal immune
inductionSpeaker: Dr. Sean
TuckerDate: Wednesday, October 18,
2023Time: 2:30 p.m. CET / 8:30 a.m. ET
Title: Protection against
infection from an oral tablet norovirus candidate in humans
Speaker: Dr. James F.
CummingsDate: Thursday, October 19, 2023
Time: 11:00 a.m. CET / 5:00 a.m. ET About
Vaxart
Vaxart is a clinical-stage biotechnology company
developing a range of oral recombinant vaccines based on its
proprietary delivery platform. Vaxart vaccines are designed to be
administered using pills that can be stored and shipped without
refrigeration and eliminate the risk of needle-stick injury. Vaxart
believes that its proprietary pill vaccine delivery platform is
suitable to deliver recombinant vaccines, positioning the company
to develop oral versions of currently marketed vaccines and to
design recombinant vaccines for new indications. Vaxart’s
development programs currently include pill vaccines designed to
protect against norovirus, coronavirus, seasonal influenza, and
respiratory syncytial virus (RSV), as well as a therapeutic vaccine
for human papillomavirus (HPV), Vaxart’s first immune-oncology
indication. Vaxart has filed broad domestic and international
patent applications covering its proprietary technology and
creations for oral vaccination using adenovirus and TLR3
agonists.
Contacts
Vaxart Media Relations: |
Investor
Relations: |
Mark Herr |
Andrew
Blazier |
Vaxart,
Inc. |
FINN
Partners |
mherr@vaxart.com |
IR@Vaxart.com |
(203)
517-8957 |
(646)
871-8486 |
Vaxart (NASDAQ:VXRT)
Historical Stock Chart
From Apr 2024 to May 2024
Vaxart (NASDAQ:VXRT)
Historical Stock Chart
From May 2023 to May 2024